CDKN2D

CDKN2D, also known as p19INK4d, is a protein that plays a role in cell cycle regulation. It is part of the INK4 family of cyclin-dependent kinase inhibitors. These inhibitors function by binding to cyclin-dependent kinases (CDKs) and preventing them from phosphorylating their target proteins, thereby halting the cell cycle. Specifically, CDKN2D inhibits CDK4 and CDK6, which are involved in the progression from the G1 phase to the S phase of the cell cycle. This inhibitory action helps to control cell proliferation and maintain genomic stability.

The gene encoding CDKN2D is located on human chromosome 16p13.3. Its expression can be induced by various stimuli, including cellular stress and DNA damage. This induction serves as a protective mechanism, pausing the cell cycle to allow for DNA repair or, if the damage is too severe, initiating apoptosis (programmed cell death). Dysregulation of CDKN2D has been implicated in the development of various cancers, where its loss or reduced function can contribute to uncontrolled cell growth and tumor formation. Research into CDKN2D's precise mechanisms and its involvement in different disease states is ongoing.